Anticipated Shortage

MYLAN-AMLODIPINE/ATORVASTATIN

MYLAN PHARMACEUTICALS ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of MYLAN-AMLODIPINE/ATORVASTATIN in Canada?

A shortage of MYLAN-AMLODIPINE/ATORVASTATIN 5MG 40MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 28, 2026), but it has not started yet.

Why is MYLAN-AMLODIPINE/ATORVASTATIN not available?

The reason the manufacturer reported: Demand increase for the drug.

When will MYLAN-AMLODIPINE/ATORVASTATIN be available again?

The manufacturer's estimated resolution date is December 8, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusAnticipated Shortage

Same-ingredient products on fileNone found

Expected resolution~26 days remaining (estimate)

Affected strength5MG 40MG

Report last updated2026-10-28

Checked by MedShort2026-11-12

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

Estimated Resolution

2026-12-08

~26 days remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02362775

Strength

5MG 40MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

AMLODIPINE ATORVASTATIN

Tier

Unrated

Last Updated

2026-10-28

Reason for Shortage

Demand increase for the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

MYLAN-AMLODIPINE/ATORVASTATIN has 2 shortage/discontinuation reports on file — this is one of them.

2026-10-14

Resolved

Demand increase for the drug.

Other Products from MYLAN PHARMACEUTICALS ULC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

AZITHROMYCIN FOR INJECTION, USP

500MG · DIN 02385473

333MG · DIN 02293269

10MG · DIN 02257955

40MG · DIN 02257963

DIN 02388138

DIN 02388146